ARPA-E detail: $4.7 million Codexis biocatalysts for power plant CO2

In California, Codexis announced that the company has been selected to receive up to a $4.7 million grant from the U.S. Department of Energy for development of biocatalysts for more efficient carbon capture from coal-fired power plants, in collaboration with CO2 Solution of Quebec City, Canada.The technology is based on customized carbonic anhydrase biocatalysts that have the potential to enable cost effective, energy efficient capture of carbon dioxide.

Codexis has commercialized its biocatalysts in the pharmaceutical industry, is developing biocatalysts for use in producing advanced biofuels, and is also using its technology platform to pursue biocatalyst-enabled solutions in carbon management, water treatment and chemicals.

More on the story.

More Coverage on this Topic

• Biofuels earnings season: Gevo, Codexis in focus
• “Our algae will eat your waste CO2 and turn it into oil.”
• Codexis loss widens in Q1, as detergent alcohols R&D weighs
• Directed evolution: the third wave in biocatalysis for advanced biofuels?
• FDA approves Codexis enzyme for Merck
• Codexis, Merck develop enzyme for bio-based production of Victrelis ingredient
• Codexis pressures Shell for extension of research partnership
• Codexis lands key renewable sugars patent

Tags: bioactalyst, CDXS, CO2, Codexis

Category: Producer News, Research